OakChart

Compass Pathways Plc ADR

CMPSHealthcare·Medical Care Facilities·United Kingdom·Small·NASD·Nov 11 • 1:55 PM ET

9.34+0.09 (0.97%)
2026-11-11 19:56 CET
Market cap
1,310.58 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-280.32 USD m
Free cash flow, TTM
-176.69 USD m
EPS diluted, TTM
-3.50
P/E
-
Compare

Price

CMPS against its 20, 50 and 200-day averages
2050200beatmiss
7.5010.0012.5015.008.4M16.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CMPSclose 9.3420-day 10.4450-day 12.06200-day 10.469.3452w high

41.1% under the 52-week high of 15.87 on 9 Sep 2026. 52-week low 4.88 on 24 Mar 2026. Last 15 sessions, 65.8% high to low

Profile

CMPS
52-week range, 41% of the way up
4.8815.87

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Employees156
IPOSep 18, 2020
Beta2.44
ATR, 14d0.84
Rel volume0.72
Short float12.34%
Insider own1.61%
Inst own65.82%

Snapshot

6 groups

Valuation

Index-
Market Cap1.32B
Enterprise Value933.28M
Income-280.32M
Sales0.00M
Book/sh1.00
Cash/sh3.14
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees156
IPOSep 18, 2020

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B9.31
P/C2.98
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio1.50
Current Ratio1.50
Debt/Eq0.38
LT Debt/Eq0.36
Option/ShortYes / Yes

Earnings

EPS (ttm)-3.50
EPS next Y-1.58
EPS next Q-0.40
EPS this Y44.85%
EPS next Y6.90%
EPS next 5Y32.20%
EPS past 3/5Y-12.71% -12.77%
Sales past 3/5Y- -
EPS Y/Y TTM16.03%
Sales Y/Y TTM-
EPS Q/Q78.32%
Sales Q/Q-
EarningsNov 03 BMO
EPS/Sales Surpr.13.77% -

Ownership

Insider Own1.61%
Insider Trans0.00%
Inst Own65.82%
Inst Trans-3.25%
ROA-72.37%
ROE-312.06%
ROIC-145.07%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-10.50%
SMA50-22.56%
SMA200-10.74%
Trades-

Technical

Shs Outstand141.68M
Shs Float139.40M
Short Float12.34%
Short Ratio5.74
Short Interest17.20M
52W High15.87 -41.15%
52W Low4.88 91.39%
Volatility8.94% 8.87%
ATR (14)0.84
RSI (14)40.38
Beta2.44
Rel Volume0.72
Avg Volume3.00M
Volume1,505,758

Performance

Perf Week8.60%
Perf Month-16.16%
Perf Quarter-29.72%
Perf Half Y-14.78%
Perf YTD35.36%
Perf Year63.86%
Perf 3Y77.23%
Perf 5Y-72.89%
Perf 10Y-
Recom1.17
Target Price22.94
Prev Close9.25
Price9.34
Change %0.97%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jul 27, 2026InitiatedWWells FargoEqual Weight$13+39.2%
Jul 08, 2026UpgradeEEvercore ISIIn-line → Outperform$21+124.8%
May 22, 2026InitiatedWWolfe ResearchOutperform
May 04, 2026InitiatedJJefferiesBuy$18+92.7%
Apr 24, 2026InitiatedRB. Riley SecuritiesBuy$17+82.0%
Dec 10, 2025UpgradeOOppenheimerPerform → Outperform$15+60.6%
Jun 23, 2025DowngradeEEvercore ISIOutperform → In-line$11 → $6-35.8%
Feb 27, 2025InitiatedSStifelBuy$11+17.8%
Jul 23, 2024InitiatedRRBC Capital MktsOutperform$23+146.3%
Apr 01, 2024InitiatedMMorgan StanleyOverweight$30+221.2%

Peers

Mkt cap
TickerCompanyMkt cap
DFTXDefinium Therapeutics Inc4.73B
HELPHelus Pharma Inc692.61M
GHRSGH Research PLC1.32B
AXSMAxsome Therapeutics Inc7.84B
DRUGBright Minds Biosciences Inc226.98M
SUPNSupernus Inc6.09B
ACADAcadia Pharmaceuticals Inc3.19B
NBIXNeurocrine Biosciences Inc17.54B
ALKSAlkermes plc7.95B
CMNDClearmind Medicine Inc2.48M

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Jenkins AnnalisaFormer DirectorAug 10 '26Proposed Sale13.3026,000345,799Aug 10 01:26 PM
Jenkins AnnalisaFormer DirectorAug 07 '26Proposed Sale13.7283,7711,149,153Aug 07 11:35 AM

Held by

AUM
TickerCompanyAUM
ARKGARK Genomic Revolution ETFAUM: 1.97B
IBBiShares Biotechnology ETFAUM: 11.36B
PSILAdvisorShares Psychedelics ETFAUM: 43.26M
SBIOALPS Medical Breakthroughs ETFAUM: 192.65M
TMSLT. Rowe Price Small-Mid Cap ETFAUM: 3.28B
GWXState Street SPDR S&P International Small Cap ETFAUM: 906.57M
SURISimplify Propel Opportunities ETFAUM: 74.30M
HTECROBO Global Healthcare Technology and Innovation ETFAUM: 112.81M
AADRAdvisorShares Dorsey Wright ADR ETFAUM: 33.73M
ONEQFidelity Nasdaq Composite Index ETFAUM: 10.35B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-03-0.310-0.360-0.0650.000.0015
2026Q22026-08-05-1.880-0.388-1.8830.000.0015
2026Q12026-05-130.710-0.439-0.3040.000.0012
2025Q42026-03-24-1.000-0.403-1.0010.000.0012
2025Q32025-11-04-1.440-0.395-1.4360.000.0010
2025Q22025-07-31-0.410-0.433-0.4170.000.0011
2025Q12025-05-08-0.240-0.467-0.2010.000.009
2024Q42025-02-27-0.630-0.626-0.6270.000.0011
2024Q32024-10-31-0.560-0.570-0.5690.000.0010
2024Q22024-08-01-0.560-0.539-0.5580.000.0010
2024Q12024-05-08-0.550-0.482-0.5480.000.006
2023Q42024-02-29-0.530-0.361-0.5300.000.007
2023Q32023-11-02-0.670-0.520-0.6690.000.0010
2023Q22023-08-03-0.620-0.714-0.6240.000.009
2023Q12023-05-11-0.570-0.691-0.5720.000.0010
2022Q42023-02-28-0.730-0.617-0.7310.000.0011

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2020FY-3.550-2.116-1.6920.000.00
2021FY-1.790-1.675-1.7930.000.00
2022FY-2.160-2.067-2.1550.000.00
2023FY-2.320-2.153-2.3310.000.00
2024FY-2.300-2.293-2.3000.000.00
2025FY-3.080-2.464-3.0770.000.00
2026FY--1.699--0.00
2027FY--1.581--29.84
2028FY--0.960--198.27
2029FY-0.198--450.08
2030FY-1.673--781.6

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-038000.000.000.00
2026Q4S2026-08-297000.000.000.00
2026Q4S2026-08-058000.000.000.00
2026Q4S2026-07-248000.000.000.00
2026Q4S2026-05-217000.000.000.00
2026Q4S2026-05-146000.000.000.00
2026Q4S2026-05-135000.000.000.00
2026Q4S2026-04-224000.000.000.00
2026Q4S2026-03-243000.000.000.00
2026Q4S2025-11-113000.000.000.00
2026Q4S2025-11-103000.000.000.00
2026Q4S2025-11-093000.000.000.00
2026Q4S2025-11-083000.000.000.00
2026Q4S2025-11-073000.000.000.00

Estimate history

EPS, annual--1.692-1.793-2.155-2.331-2.3-3.086-3.4995
Period2019202020212022202320242025TTM
EPS, quarterly-0.569-0.627-0.201-0.417-1.436-1.001-0.304-1.883-0.311
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00000000
Period2019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual-35.9342.0242.63261.94368.55296.086141.684
Period2019202020212022202320242025MRQ
Shares, quarterly68.40968.55292.84893.58696.00296.086134.923135.722141.684
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.010.220.230.240.330.170.110.06
Gross Profit-0.01-0.22-0.23-0.24-0.33-0.17-0.11-0.06
Selling, General and Administrative Excl. Other197.59179.24178.05137.21110.0183.0451.6821.20
Research and Development108.97118.71119.0987.8665.0144.0223.5512.62
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-197.59-179.46-178.28-137.45-110.33-83.21-51.79-21.27
Interest Expense5.594.534.482.210.000.000.00-
Unusual Expense72.60122.850.000.000.000.001.781.14
Net Income Before Taxes-264.50-294.77-174.70-131.07-105.46-81.18-65.05-22.42
Income Taxes2.27-6.23-19.51-12.14-14.01-9.45-4.25-2.73
Consolidated Net Income-280.32-288.53-155.19-118.92-91.45-71.73-60.80-19.69
Net Income From Continuing Operations-280.32-288.53-155.19-118.92-91.45-71.73-60.80-19.69
Net Income-280.32-288.53-155.19-118.92-91.45-71.73-60.80-19.69
EPS (Recurring)-2.38-2.17-2.30-2.33-2.15-1.79-1.66-
EPS (Basic, Before Extraordinaries)-2.25-3.09-2.30-2.33-2.15-1.79-1.69-
EPS (Diluted)-3.50-3.09-2.30-2.33-2.15-1.79-1.69-
EBITDA-197.59-179.24-178.05-137.21-110.01-83.04-51.68-21.20
Non-Operating Income (Expense)11.2812.068.068.604.882.03-11.47-0.01
Other After Tax Adjustments-13.540.000.000.000.000.000.000.00
Stock Option Compensation Expense11.2410.7615.4213.7010.627.0014.682.65
Shares Outstanding141.6896.0968.5561.9442.6342.0235.93-
Market Capitalization1,310.581,310.58258.63541.49341.71922.261,711.721,741.90

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.000.000.010.010.160.040.05
Gross Profit0.000.000.00-0.01-0.01-0.16-0.04-0.05
Selling, General and Administrative Excl. Other56.4152.4742.8345.8840.2743.3049.7747.92
Research and Development23.4529.2326.4429.8627.1530.7031.0031.84
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-56.41-52.47-42.83-45.89-40.28-43.46-49.81-47.97
Interest Expense1.501.491.461.141.101.171.131.12
Unusual Expense-40.76205.95-130.7038.11100.692.57-19.530.00
Net Income Before Taxes-12.98-256.5188.57-83.58-140.99-43.08-26.06-52.03
Income Taxes-3.15-2.26-2.4810.16-4.13-4.20-8.13-9.09
Consolidated Net Income-9.83-254.2577.50-93.74-136.86-38.88-17.93-42.93
Net Income From Continuing Operations-9.83-254.2577.50-93.74-136.86-38.88-17.93-42.93
Net Income-9.83-254.2577.50-93.74-136.86-38.88-17.93-42.93
EPS (Recurring)-0.49-0.82-1.01-0.72-0.70-0.40-0.35-0.63
EPS (Basic, Before Extraordinaries)-0.07-1.880.70-1.00-1.44-0.42-0.20-0.63
EPS (Diluted)-0.31-1.88-0.30-1.00-1.44-0.42-0.20-0.63
EBITDA-56.41-52.47-42.83-45.88-40.27-43.30-49.77-47.92
Non-Operating Income (Expense)4.173.392.161.551.084.125.34-2.94
Other After Tax Adjustments0.000.00-13.540.000.000.000.000.00
Stock Option Compensation Expense3.523.192.282.252.522.883.123.52
Shares Outstanding141.68135.72134.9296.0996.0093.5992.8568.55
Market Capitalization1,310.581,909.16531.35662.41536.25259.98196.06258.63

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments149.99165.47220.64143.38273.35190.3624.98
Short Term Receivables15.3921.8228.9315.6211.225.785.22
Inventories0.000.000.000.000.000.000.00
Other Current Assets26.1214.0011.7332.659.906.271.85
Total Current Assets191.49201.29261.30191.65294.46202.4032.06
Net Property, Plant & Equipment3.422.204.732.624.090.250.22
Total Investments and Advances0.000.470.470.470.530.530.00
Long-Term Note Receivable10.95------
Intangible Assets------0.00
Deferred Tax Assets3.753.773.342.220.770.22-
Other Assets0.735.946.160.331.050.060.12
Total Assets210.35213.67275.99197.29300.90203.4632.39
Short Term Debt Incl. Current Port. of LT Debt19.637.242.411.512.230.0021.09
Accounts Payable15.2212.280.000.000.002.751.32
Income Tax Payable----0.000.24-
Other Current Liabilities212.9414.4917.1914.0912.873.901.46
Total Current Liabilities247.7934.0219.6015.6015.116.8923.87
Long Term Debt15.4024.9530.640.421.380.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.000.00
Total Liabilities263.2058.9750.2416.0116.496.8923.87
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.0038.91
Common Equity-52.85154.69225.74181.28284.41196.56-30.39
Total Shareholders Equity-52.85154.69225.74181.28284.41196.568.52
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity-52.85154.69225.74181.28284.41196.568.52
Total Liabilities & Stockholders Equity210.35213.67275.99197.29300.90203.4632.39
Book Value Per Share-0.552.263.644.256.775.47-
Tangible Book Value Per Share-0.552.263.644.256.775.47-
Full-Time Employees156166186181116--
Price to Book Ratio9.231.342.141.763.278.718.58
Return on Assets-136.10-63.39-50.25-36.71-28.45-51.56-
Return on Equity-566.60-81.58-58.44-39.27-29.83-59.30-
Return on Invested Capital--86.38-46.38-50.33-25.10-30.93-231.19
Quick Ratio0.775.9213.3312.2919.4929.361.34
Current Ratio0.775.9213.3312.2919.4929.361.34

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-266.21-288.53-155.19-118.92-91.45-71.73-60.80-19.69
Depreciation0.010.220.230.240.330.170.110.06
Other Funds (Non Cash)90.43144.9923.9917.4316.3810.4619.684.41
Funds from Operations-175.78-143.33-130.96-101.25-74.74-61.10-41.01-15.22
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-0.91-14.2811.733.50-30.65-6.64-0.70-2.67
Cash from Operating Activities-176.69-157.61-119.24-97.75-105.39-67.74-41.70-17.89
Capital Expenditures0.000.000.00-0.07-0.60-0.33-0.13-0.17
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00-0.500.00
Purchase of Investments0.000.000.000.000.000.00-0.500.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities0.000.000.00-0.06-0.60-0.33-0.63-0.17
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock414.69141.0464.09145.851.04156.63195.67-0.06
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock414.69141.0464.09145.851.04156.63195.67-0.06
Proceedsfrom Stock Options166.29141.0126.60145.850.64156.63195.65-0.06
Issuance or Reduction of Debt, Net18.580.000.0028.920.000.000.0018.51
Change in Long Term Debt18.580.000.0028.920.000.000.000.00
Issuance of Long Term Debt18.580.000.0029.700.000.000.000.00
Reduction of Long Term Debt0.000.000.00-0.780.000.000.000.00
Net Financing Active Other Cash Flow-0.310.00-0.24-0.270.000.000.000.00
Other Financing Activities Uses-0.310.00-0.24-0.270.000.000.000.00
Cash from Financing Activities432.96141.0463.85174.501.04156.63195.6718.46
Exchange Rate Effect1.601.050.190.87-24.94-5.5813.331.68
Net Change in Cash257.87-15.52-55.1977.56-129.8982.98166.662.09
Free Cash Flow-176.69-157.61-119.24-97.82-105.98-68.07-41.83-18.05
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00-
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments444.40433.72466.39149.99186.32222.26
Short Term Receivables15.2115.1515.1315.3940.3137.33
Inventories0.000.000.000.000.000.00
Other Current Assets27.9426.8029.3526.1215.7616.82
Total Current Assets487.55475.67510.87191.49242.39276.40
Net Property, Plant & Equipment3.453.942.863.423.934.34
Total Investments and Advances0.000.000.000.000.000.00
Deferred Tax Assets5.114.554.103.754.534.29
Other Assets22.9820.3913.910.734.768.50
Total Assets519.10504.56531.74210.35255.61293.54
Short Term Debt Incl. Current Port. of LT Debt3.231.882.0519.6314.6210.03
Accounts Payable8.9912.2410.8815.225.2510.93
Other Current Liabilities313.65353.16140.87212.94177.5910.37
Total Current Liabilities325.86367.29153.80247.79197.4531.33
Long Term Debt51.1752.7451.2615.4020.5725.25
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.0074.40
Total Liabilities377.03420.03205.05263.20218.02130.98
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity142.0784.53326.69-52.8537.59162.56
Total Shareholders Equity142.0784.53326.69-52.8537.59162.56
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity142.0784.53326.69-52.8537.59162.56
Total Liabilities & Stockholders Equity519.10504.56531.74210.35255.61293.54
Book Value Per Share1.000.622.42-0.550.391.74
Tangible Book Value Per Share1.000.622.42-0.550.391.74
Full-Time Employees---156--
Price to Book Ratio9.235.84-10.0517.623.301.33
Return on Assets-72.37-102.08-45.12-135.57-94.09-48.47
Return on Equity-312.06-329.72-73.53-564.40-205.18-71.31
Return on Invested Capital-5.09-185.2120.51--235.32-20.70
Quick Ratio1.501.303.320.771.238.82
Current Ratio1.501.303.320.771.238.82

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-9.80-253.6191.05-93.85-137.93-38.82
Depreciation0.000.000.000.010.010.16
Other Funds (Non Cash)-34.10210.02-127.6642.17106.416.65
Funds from Operations-43.90-43.59-36.61-51.67-31.51-32.01
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-6.833.22-11.2513.95-3.30-7.23
Cash from Operating Activities-50.74-40.37-47.86-37.73-34.81-39.24
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.000.000.000.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock63.088.31343.300.01-0.700.83
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock63.088.31343.300.01-0.700.83
Proceedsfrom Stock Options24.13-201.10343.27-0.01-0.540.67
Issuance or Reduction of Debt, Net-0.000.0318.550.000.000.00
Change in Long Term Debt-0.000.0318.550.000.000.00
Issuance of Long Term Debt-0.000.0318.550.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow-0.07-0.240.000.000.000.00
Other Financing Activities Uses-0.07-0.240.000.000.000.00
Cash from Financing Activities63.018.10361.850.01-0.700.83
Exchange Rate Effect-1.640.081.881.28-0.840.30
Net Change in Cash10.63-32.19315.87-36.44-36.36-38.11
Free Cash Flow-50.74-40.37-47.86-37.73-34.81-39.24

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3012.34%17.2M139.4M2.65M
2026-10-1512.97%17.7M136.2M2.96M
2026-09-3012.50%17.0M136.2M3.34M
2026-09-1511.18%15.2M136.2M3.40M
2026-08-3110.62%14.5M136.2M3.58M
2026-08-1410.56%14.1M133.5M3.92M
2026-07-3110.53%13.6M129.5M4.03M
2026-07-159.98%12.8M128.7M4.87M
2026-06-307.90%10.2M128.7M4.27M
2026-06-156.49%8.4M128.7M4.09M
2026-05-295.69%7.3M128.7M3.89M
2026-05-155.98%7.7M128.7M4.58M
2026-04-3010.44%9.8M93.5M4.18M
2026-04-1511.78%11.0M93.5M2.89M
2026-03-319.51%8.9M93.5M2.93M
2026-03-136.83%6.4M93.4M2.65M
2026-02-276.73%6.3M93.4M2.50M
2026-02-135.85%5.5M93.4M1.38M
2026-01-306.60%6.2M94.1M1.64M
2026-01-155.35%5.0M94.1M1.63M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call1.007.609.108.0621.58033.000.000.992-0.0150.000
call2.006.608.1011.2512.17919.000.000.987-0.0150.000
call3.005.607.106.608.9592.000.000.982-0.0150.001
call4.004.806.0010.306.5260.000.000.976-0.0150.001
call5.003.705.008.255.14342.000.000.968-0.0150.001
call6.002.803.902.753.7962490.000.958-0.0140.001
call7.001.952.651.322.23334.000.000.941-0.0130.002
call8.001.201.601.401.4091,1051.000.837-0.0230.004
call9.000.600.850.651.0907638.000.618-0.0340.006
call10.000.250.350.300.9541,38250.000.352-0.0300.005
call11.000.050.150.101.0838860.000.187-0.0240.004
call12.000.000.050.051.2634,3903.000.120-0.0210.003
call13.000.000.100.051.5265,20615.000.104-0.0230.003
call14.000.000.050.151.5214,7860.000.057-0.0140.002
call15.000.000.050.031.7791,6801.000.052-0.0150.002
call16.000.000.200.131.8972,2020.000.048-0.0160.001
call17.000.000.050.052.0611,08016.000.045-0.0160.001
call18.000.000.150.032.2138980.000.043-0.0170.001
call19.000.000.050.082.3431520.000.041-0.0170.001
call20.000.000.250.052.4861,7900.000.039-0.0170.001
call21.000.000.750.302.60994.000.000.038-0.0180.001
call22.000.000.750.172.7264430.000.036-0.0180.001
call23.000.000.200.052.8353770.000.035-0.0180.001
call24.000.000.750.202.9402410.000.034-0.0180.001
call25.000.000.750.133.03978.000.000.034-0.0190.001
call26.000.000.750.463.1336.000.000.033-0.0190.001
call27.000.000.100.403.46570.000.000.055-0.0300.002
call28.000.000.050.023.18566.000.000.032-0.0170.001
put1.000.000.050.007.6540.000.00-0.008-0.0130.000
put2.000.000.750.215.4871.000.00-0.013-0.0150.000
put3.000.000.750.004.0770.000.00-0.018-0.0150.001
put4.000.000.950.053.13935.000.00-0.024-0.0150.001
put5.000.000.050.033.24150.000.00-0.077-0.0370.002
put6.000.000.450.051.7882890.00-0.042-0.0130.001
put7.000.000.050.111.2539590.00-0.059-0.0120.002
put8.000.100.150.131.0981,7370.00-0.163-0.0220.004
put9.000.350.400.401.0523,19917.00-0.382-0.0330.006
put10.000.851.050.961.10012,2051.00-0.648-0.0290.005
put11.001.701.901.921.2751,1367.00-0.813-0.0230.004
put12.002.303.202.802.2875330.00-0.880-0.0190.003
put13.003.303.803.702.4223,2433.00-0.897-0.0210.003
put14.004.004.902.872.2183290.00-0.943-0.0130.002
put15.005.006.005.852.73549.001.00-0.948-0.0130.002
put16.005.907.307.703.69872.000.00-0.952-0.0140.001
put17.006.908.305.803.94036.000.00-0.955-0.0140.001
put18.007.909.309.753.95242.000.00-0.957-0.0140.001
put19.009.2010.309.804.3401.000.00-0.959-0.0150.001
put20.0010.1011.3011.804.5020.000.00-0.961-0.0150.001
put21.0010.4012.700.005.5020.000.00-0.962-0.0150.001
put22.0011.4013.700.005.5610.000.00-0.964-0.0150.001
put23.0012.4014.700.005.7750.000.00-0.965-0.0160.001
put24.0014.3015.700.005.9630.000.00-0.966-0.0160.001
put25.0015.2016.7016.805.9920.000.00-0.966-0.0160.001
put26.0015.4017.700.006.1210.000.00-0.967-0.0160.001
put27.0017.4018.8017.906.5260.002.00-0.968-0.0160.001
put28.0017.1019.700.006.3610.000.00-0.969-0.0160.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-038-KCurrent report2026-11-03SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-28SCHEDULE 13GSEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-07144Filing for proposed sale of securities under Rule 144.SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-05S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuersSEC
2026-08-058-KCurrent report2026-08-05SEC
2026-08-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-078-KCurrent report2026-07-07SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-293Initial statement of beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-294Statement of changes in beneficial ownership of securities2026-05-27SEC
2026-05-288-KCurrent report2026-05-27SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-138-KCurrent report2026-05-13SEC
2026-05-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-15ARSAnnual report to security holders. 2025-12-31SEC
2026-04-15DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-27SEC
2026-03-274Statement of changes in beneficial ownership of securities2026-03-26SEC
2026-03-274Statement of changes in beneficial ownership of securities2026-03-26SEC
2026-03-274Statement of changes in beneficial ownership of securities2026-03-26SEC
2026-03-24S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-03-24S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
Deep Track Capital, LP9.01%
RTW INVESTMENTS, LP7.93%
BIT Capital GmbH4.71%
TANG CAPITAL MANAGEMENT LLC3.71%
TWO SIGMA INVESTMENTS, LP3.31%
MARSHALL WACE, LLP3.21%
ARK Investment Management LLC2.56%
UBS Group AG2.25%
Point72 Asset Management, L.P.1.94%
Logos Global Management LP1.67%

Funds

Fund% owned
ARK Genomic Revolution ETF3.31%
iShares Biotechnology ETF0.57%
Columbia Small Cap Value Discovery Fund0.44%
AdvisorShares Psychedelics ETF0.27%
Royce Smaller-Companies Growth Fund0.13%
ALPS Medical Breakthroughs ETF0.12%
Goldman Sachs Small Cap Growth Fund0.11%
Simplify Propel Opportunities ETF0.08%
Adara Smaller Companies Fund0.08%
ROYCE SMALL-CAP TRUST, INC.0.07%

OakChart. CMPS. Cached 15 minutes.